Extracorporeal Shock Wave Therapy in Patients With Lipedema
ConditionLipedema
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorAtlas University
About this trial
Lipedema is a chronic adipose tissue disorder characterized by pain, tenderness, disproportionate fat accumulation, and impaired quality of life. Extracorporeal shock wave therapy (ESWT) has been proposed as a non-invasive treatment option that may improve pain and tissue characteristics in patients with lipedema.
The aim of this prospective interventional study is to evaluate the effects of ESWT on pain intensity, quality of life, functional outcomes, and ultrasonographic findings in patients diagnosed with lipedema. Participants will receive a standardized ESWT protocol consisting of six treatment sessions over a two-week period. Clinical assessments and ultrasonographic examinations will be performed before and after treatment.
Eligibility criteria
Qualifiers
Male or female participants aged 18 to 75 years
Clinical diagnosis of lipedema
Willingness to participate and provide written informed consent
Ability to comply with study procedures and follow-up assessments
Disqualifiers
Pregnancy or breastfeeding
Active infection in the treatment area
Malignancy
Severe cardiovascular disease
Trial design
Treatments tested in this trial
- Extracorporeal Shock Wave Therapy
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov